南華期貨股份有限公司 章 程 | 第一章 | 總 | | | 則 | 1 | | | --- | --- | --- | --- | --- | --- | --- | | 第二章 | | 經營宗旨和範圍 | | | 3 | | | 第三章 | 股 | 份 | | | 3 | | | 第一節 | | 股份發行 | | | 3 | | | 第二節 | | 股份增減和回購 | | | 5 | | | 第三節 | | 股份轉讓 | | | 6 | | | 第四章 | | 股東和股東會 | | | 8 | | | 第一節 | | 股東的一般規定 | | | 8 | | | 第二節 | | 控股股東和實際控制人 | | | 13 | | | 第三節 | | 股東會的一般規定 | | | 15 | | | 第四節 | | 股東會的召集 | | | 17 | | | 第五節 | | 股東會的提案與通知 | | | 19 | | | 第六節 | | 股東會的召開 | | | 22 | | | 第七節 | | 股東會的表決和決議 | | | 26 | | | 第五章 | | 董事和董事會 | | | 31 | | | 第一節 ...

New IPOs - The largest biotech IPO in Hong Kong for 2025 is initiated by Insilico Medicine (03696), which boasts the fastest global progress in AI drug development [1] - Lin Qingxuan (02657) will conduct its IPO from December 18 to December 23, attracting cornerstone investors like Fidelity [1] - Woan Robotics (06600) is set to launch its IPO during the same period, with an expected listing date of December 30 [1] - Meilian Holdings (02671) and Wuyi Vision (06651) will also hold their IPOs from December 18 to December 23, both expected to list on December 30 [1] - Xun Ce (03317) will follow the same IPO schedule, with a listing anticipated on December 30 [1] - Zhihui Mining (02546) achieved a remarkable 5248.15 times subscription in its public offering, with a listing date of December 19 [1] - China National Airlines (00753) plans to invest in Shenzhen Airlines' equity financing, with Kunhang Investment, a state-owned entity, being shortlisted [1] - Sensetime-W (00020) intends to place 1.75 billion new Class B shares, aiming to raise approximately HKD 3.146 billion [1] - Fosun Pharma (02196) is enhancing its overseas innovative drug strategy by signing a cooperation and option agreement with Clavis Bio [1] - WuXi AppTec (02359) invested around EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [1] - Minhua Holdings (01999) plans to acquire 100% equity in the American soft furniture company Gainline Recline Intermediate Corp [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.055 million shares for HKD 636 million on December 18 [2] - Xiaomi Group-W (01810) spent HKD 151 million to buy back 3.75 million shares on the same day [2] - COSCO Shipping Holdings (01919) repurchased 5.9 million shares for HKD 80.557 million [2] - Country Garden Services (06098) bought back 2.7 million shares for HKD 17.136 million [2] - Jiangsu Ninghu Expressway (00177) saw an increase of 52.862 million shares by Yunsong Capital [2]

Core Viewpoint - The Hong Kong stock market is becoming a significant platform for financial institutions to expand globally, with Nanhua Futures set to list on December 22, marking a new phase of development through its "A+H" dual capital platform [1] Group 1: Company Overview - Nanhua Futures, established in 1996, is one of the first companies in China's futures industry and focuses on core businesses in futures and derivatives, becoming a comprehensive global financial service platform [2] - According to Frost & Sullivan, Nanhua Futures ranks eighth among all futures companies in China by total revenue in 2024 and holds the top position among non-financial institution-related futures companies [2] Group 2: Service Offerings - Nanhua Futures has built a comprehensive service system covering the futures and derivatives value chain, including domestic futures brokerage, risk management services, wealth management, and overseas financial services [3] - The product portfolio includes various asset classes such as agricultural products, industrial products, energy, metals, stocks, and fixed income securities, catering to diverse needs of industrial clients, financial institutions, and individual investors [3] Group 3: Global Expansion and Performance - Since 2006, Nanhua Futures has actively pursued internationalization, establishing a business network across major financial centers including Hong Kong, Chicago, Singapore, and London, holding 17 overseas exchange memberships and 14 clearing seats [4] - The number of registered clients in domestic futures brokerage increased from 4,266 in 2022 to 5,279 by mid-2025, while the number of registered financial institution clients rose from 1,140 to 1,872 [4] - Client equity in domestic futures brokerage reached 31.6 billion yuan by the end of 2024, a 65.4% increase from 2022, significantly exceeding the industry’s 1.9% compound annual growth rate [4] Group 4: Financial Performance - Nanhua Futures achieved steady growth in profits, with annual profits increasing from 246 million yuan in 2022 to 458 million yuan in 2024, reflecting a compound annual growth rate of 36.5% [5] - Total assets grew from 34.189 billion yuan at the end of 2022 to 48.863 billion yuan by the end of 2024, with a compound annual growth rate of 19.5% [5] - Return on equity (ROE) improved from 7.75% in 2022 to 11.71% in 2024, with a figure of 5.51% for the first half of 2025 [5] Group 5: Future Outlook - The Chinese futures market is the largest commodity market globally, and with the increasing pace of Chinese enterprises going global, Nanhua Futures is positioned for broader development prospects [6] - The company plans to use the net proceeds from its H-share listing to strengthen its capital base in overseas markets, enhancing its global service network [6] - Nanhua Futures is expected to benefit from market opening incentives and continue leading in the global financial services sector while providing long-term value returns to investors [6]

该信息由智通财经网提供 假设全球发售于2025年12月22日(星期一)上午八时正或之前成为无条件，预期H股将于2025年12月22日 (星期一)上午九时正开始在联交所主板买卖。H股将以每手买卖单位500股H股买卖。H股的股份代号为 02691。 智通财经APP讯，南华期货股份(02691)发布公告，于2025年12月18日(星期四)，发售价已厘定为每股H 股12.00港元。 ...

Core Viewpoint - The A+H listing strategy is becoming a consensus among industry leaders, with companies like Nanhua Futures taking significant steps towards internationalization through its H-share listing in Hong Kong, marking a milestone for the Chinese futures industry [1][2]. Group 1: Industry Trends - The A+H listing trend is characterized by leading companies from various sectors, including manufacturing and new energy, actively seeking to expand their international financing channels by listing in Hong Kong [1]. - As of the latest data, 17 A-share companies have successfully issued H-shares in Hong Kong this year, covering key sectors such as electronics, new energy, manufacturing, and finance [1]. Group 2: Company Strategy - Nanhua Futures' H-share listing is a crucial step in its internationalization strategy, having established a service network across major global financial centers since 2006 [2]. - The expected net fundraising amount from the H-share issuance is over 1.4 billion HKD, which will be used to enhance the scale and optimize the structure of its overseas business [2]. Group 3: Business Development - Nanhua Futures reported revenues of 941 million CNY and a net profit of 351 million CNY for the first three quarters of 2025, with total assets reaching 64.079 billion CNY [3]. - The company has achieved significant growth in its overseas business, with revenues increasing from 231 million CNY in 2022 to 654 million CNY in 2024, reflecting a compound annual growth rate of 68.3% [2][3]. Group 4: Market Position and Future Outlook - The Chinese futures market saw a transaction volume of 675 trillion CNY in the first 11 months of 2025, a year-on-year increase of 20.19%, indicating strong demand for hedging and asset allocation [4]. - Nanhua Futures is positioned to leverage its A+H dual capital platform to enhance its core competitiveness and solidify its industry position, benefiting from the Belt and Road Initiative and the accelerated opening of the futures market [4].

格隆汇12月18日丨南华期货股份(02691.HK)公告，于2025年12月18日(星期四)，发售价已厘定为每股H 股12.00港元(不包括1%经纪佣金、0.0027%证监会交易徵费、0.00015%会财局交易徵费及0.00565%联交 所交易费)。 公司预期于2025年12月19日(星期五)，按照招股章程「如何申请香港发售股份－B.公布结果」一节所述 方式，公布国际发售踊跃程度、香港公开发售的申请水平、香港发售股份分配基准及香港公开发售的分 配结果。 假设全球发售于2025年12月22日(星期一)上午八时正或之前成为无条件，预期H股将于2025年12月22日 (星期一)上午九时正开始在联交所主板买卖。H股将以每手买卖单位500股H股买卖。H股的股份代号为 02691。 ...

香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及 香 港 中 央 結 算 有 限 公 司（「香港結算」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 不 會 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 依 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 除 本 公 告 另 有 界 定 者 外，本 公 告 所 用 詞 彙 與 南 華 期 貨 股 份 有 限 公 司（「本 公 司」）日 期 為2025年12月12日 的 招 股 章 程（「招股章程」）所 界 定 者 具 有 相 同 涵 義。 本 公 告 僅 作 說 明 用 途，並 不 構 成 收 購、購 買 或 認 購 任 何 證 券 的 邀 請 或 要 約。本 公 告 並 非 招 股 章 程。有 意 投 資 者 於 決 定 是 否 投 資 於 發 售 股 份 前 應 閱 覽 招 股 章 程，以 獲 得 有 關 下 文 所 述 全 球 發 售 的 詳 細 資 料 ...

Group 1 - Nanhua Futures Co., Ltd. has passed the listing hearing on the Hong Kong Stock Exchange [1]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Post Hearing Information Pack, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Post Hearing Information Pack. Post Hearing Information Pack of Nanhua Futures Co., Ltd. 南華期貨股份有限公司 (A joint stock company incorporated in the ...

香港聯合交易所有限公司與證券及期貨事務監察委員會對本聆訊後資料集的內容概不負 責，對其準確性或完整性亦不發表任何意見，並明確表示概不就因本聆訊後資料集全部 或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Nanhua Futures Co., Ltd. 南華期貨股份有限公司 （於中華人民共和國註冊成立的股份有限公司，中文公司名稱為「南華期貨股份有限公司」， 在香港以橫華國際名義開展業務） 的聆訊後資料集 警告 本聆訊後資料集乃根據香港聯合交易所有限公司（「聯交所」）及證券及期貨事務監察委員會（「證監會」） 的要求而刊發，僅用作提供資訊予香港公眾人士。本聆訊後資料集為草擬本，其內所載資訊並不完整， 亦可能會作出重大變動。 閣下閱覽本文件，即代表 閣下知悉、接納並向南華期貨股份有限公司（「本公司」）、其獨家保薦人、整 體協調人、顧問、或承銷團成員表示同意： 倘於適當時候向香港公眾人士提出要約或邀請，有意投資者務請僅依據與香港公司註冊處處長註冊的 本公司文件作出投資決定；文件的文本將於發售期內向公眾人士提供。 (a) 本文件僅為向香港公眾人士提供有關本公司的資料，概無任何其他目的。投資者不應根據 ...